Time for Isoniazid Pharmacogenomic-Guided Therapy of Tuberculosis Based on NAT2 Acetylation Profiles in India Nikhat KhanAparup Das Current Opinion 28 March 2022 Pages: 443 - 447
Systematic Review and Pharmacokinetic Meta-analysis of Doxorubicin Exposure in Transcatheter Arterial Chemoembolization and Doxorubicin-Eluted Beads Chemoembolization for Treatment of Unresectable Hepatocellular Carcinoma Mohammadreza ZarisfiArta KasaeianEleni Liapi Systematic Review 11 May 2022 Pages: 449 - 466
Characterization of Correction Factors to Enable Assessment of Clinical Risk from In Vitro CYP3A4 Induction Data and Basic Drug-Drug Interaction Models Diane RamsdenCody L. Fullenwider Original Research Article Open access 28 March 2022 Pages: 467 - 482
A Mechanistic Absorption and Disposition Model of Ritonavir to Predict Exposure and Drug–Drug Interaction Potential of CYP3A4/5 and CYP2D6 Substrates Sumit AroraAmita PansariIain Gardner Original Research Article 29 April 2022 Pages: 483 - 495
Population Pharmacokinetic Modelling of Acetaminophen and Ibuprofen: the Influence of Body Composition, Formulation and Feeding in Healthy Adult Volunteers James D. MorseIoana StanescuBrian J. Anderson Original Research Article Open access 02 April 2022 Pages: 497 - 507
Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study Nan-nan ChuKai HuangQing He Original Research Article 16 April 2022 Pages: 509 - 521
A Population Pharmacokinetic Model of Whole-Blood and Intracellular Tacrolimus in Kidney Transplant Recipients Linda G. FrankenMarith I. FranckeBrenda C. M de Winter Original Research Article Open access 20 April 2022 Pages: 523 - 535
Integrated Population Pharmacokinetic Analysis of Ustekinumab Across Multiple Immune-Mediated Inflammatory Disease Populations and Healthy Subjects Jie ShaoZhenhua XuYan Xu Original Research Article 20 April 2022 Pages: 537 - 548
Results From Phase I Studies Investigating the Dose Linearity of Finerenone Tablets and the Influence of Food or pH-Modifying Comedications on its Pharmacokinetics in Healthy Male Volunteers Roland HeinigJohannes NagelschmitzStephanie Loewen Original Research Article 25 May 2022 Pages: 549 - 559
Therapeutic Drug Monitoring and Prolonged Infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa Infections: An Observational Study María Eugenia Navarrete-RoucoSònia LuqueSantiago Grau Original Research Article 03 June 2022 Pages: 561 - 566
Bioavailability Study of a Transdermal Patch Formulation of Rivastigmine Compared with Exelon in Healthy Subjects Adelaida MorteAnna VaquéBjoern Schurad Original Research Article 13 June 2022 Pages: 567 - 578
An Open Label, Phase 1, Randomized, Seven-treatment, Seven-period, Crossover Study to Assess the Relative Bioavailability, pH Effect, Food Effect, and Dose Proportionality of CC-292, a Potent and Orally Available Bruton’s Tyrosine Kinase Inhibitor Yiming ChengLiangang LiuYan Li Original Research Article 03 June 2022 Pages: 579 - 592
Pharmacokinetic and Pharmacodynamic Properties of Indole-3-carbinol in Experimental Focal Ischemic Injury Kakarla RamakrishnaShreyans K. JainSairam Krishnamurthy Original Research Article 28 April 2022 Pages: 593 - 605
